Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons.
Animals
Central Amygdaloid Nucleus
/ drug effects
Corticotropin-Releasing Hormone
/ pharmacology
Dose-Response Relationship, Drug
Excitatory Postsynaptic Potentials
/ drug effects
Female
Inhibitory Postsynaptic Potentials
/ drug effects
Male
Mice
Mice, Transgenic
Neurons
/ drug effects
Receptors, Corticotropin-Releasing Hormone
/ agonists
Sex Characteristics
Astressin 2B
CRF
CeA
Female
GABA
R121919
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
received:
24
04
2020
revised:
26
08
2020
accepted:
30
08
2020
pubmed:
21
9
2020
medline:
28
8
2021
entrez:
20
9
2020
Statut:
ppublish
Résumé
The central amygdala (CeA) is a critical regulator of emotional behavior that has been implicated in psychiatric illnesses, including anxiety disorders and addiction. The CeA corticotropin releasing factor receptor 1 (CRF1) system has been implicated in alcohol use disorder (AUD) and mood disorders, and has been shown to regulate anxiety-like behavior and alcohol consumption in rodents. However, the effects of CRF signaling within the CRF receptor 1-containing (CRF1+) population of the CeA remain unclear, and the effects of ethanol and CRF1 manipulations in female rodents have not been assessed. Here, we characterized inhibitory control and CRF1 signaling in male and female CRF1-GFP reporter mice. Male and female CRF1+ CeA neurons exhibited similar baseline GABAergic signaling and excitability and were comparably sensitive to CRF-induced increases in presynaptic GABA release. CRF1 antagonism reduced GABA release onto CRF1-containing neurons comparably in both males and females. Acute ethanol application reduced GABA release onto CRF1+ neurons from males, but female CRF1+ neurons were insensitive to ethanol. Exogenous CRF increased the firing rate of CRF1-containing neurons to a greater extent in male cells versus female cells, and CRF1 antagonism reduced firing in females but not males. Together, these findings indicate a critical sex-specific role for the CRF system in regulating inhibitory control and excitability of CRF1-containing neurons in the central amygdala. Sex differences in sensitivity of CRF/CRF1 signaling provide useful context for the sex differences in psychiatric illness reported in human patients, particularly AUD.
Identifiants
pubmed: 32950560
pii: S0028-3908(20)30364-6
doi: 10.1016/j.neuropharm.2020.108296
pmc: PMC8207535
mid: NIHMS1631971
pii:
doi:
Substances chimiques
Receptors, Corticotropin-Releasing Hormone
0
CRF receptor type 1
5CLY6W2H1M
Corticotropin-Releasing Hormone
9015-71-8
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108296Subventions
Organisme : NIAAA NIH HHS
ID : P50 AA011605
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA007573
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA023002
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA026858
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA023002
Pays : United States
Organisme : NIAAA NIH HHS
ID : P60 AA011605
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Alcohol. 2018 Nov;72:61-73
pubmed: 30220589
eNeuro. 2019 Jun 18;6(3):
pubmed: 31167849
Mol Psychiatry. 2010 Sep;15(9):877, 896-904
pubmed: 20548297
Neuron. 2017 Jan 4;93(1):164-178
pubmed: 28017470
Br J Pharmacol. 2002 Jul;136(6):896-904
pubmed: 12110614
Biol Psychiatry. 2010 May 1;67(9):831-9
pubmed: 20060104
Nat Neurosci. 2017 Mar;20(3):385-388
pubmed: 28135239
Neuropsychopharmacology. 1997 Nov;17(5):308-16
pubmed: 9348546
Neuropharmacology. 2013 Apr;67:337-48
pubmed: 23220399
Pharmacol Rev. 2016 Apr;68(2):242-63
pubmed: 26772794
J Neurosci. 2019 Feb 6;39(6):1030-1043
pubmed: 30530860
Neuron. 2018 Oct 24;100(2):436-452
pubmed: 30359607
J Neurosci. 2013 Feb 20;33(8):3284-98
pubmed: 23426657
Nat Neurosci. 2014 Dec;17(12):1635-43
pubmed: 25402855
J Neurosci. 2018 Feb 21;38(8):1874-1890
pubmed: 29352046
Nat Rev Neurosci. 2004 Nov;5(11):844-52
pubmed: 15496862
J Comp Neurol. 2008 Dec 1;511(4):479-96
pubmed: 18853426
Neuropharmacology. 2016 Aug;107:239-250
pubmed: 27016019
J Neurosci. 2008 Apr 9;28(15):3861-76
pubmed: 18400885
Nature. 2011 Mar 17;471(7338):358-62
pubmed: 21389985
Alcohol. 2018 Nov;72:33-47
pubmed: 30217435
Nature. 2017 Feb 2;542(7639):96-100
pubmed: 28117439
Mol Psychiatry. 2013 Feb;18(2):166-73
pubmed: 22508464
ScientificWorldJournal. 2009 Jan 18;9:68-85
pubmed: 19151899
J Neurosci. 1995 Oct;15(10):6340-50
pubmed: 7472399
J Comp Neurol. 2006 Aug 20;497(6):910-27
pubmed: 16802333
J Comp Neurol. 2000 Dec 11;428(2):191-212
pubmed: 11064361
Biol Psychiatry. 2017 Oct 1;82(7):500-510
pubmed: 28209423
J Neurosci. 2016 Oct 19;36(42):10729-10741
pubmed: 27798128
Neuropsychopharmacology. 2006 Mar;31(3):544-54
pubmed: 16123744
Neuropharmacology. 2017 Oct;125:197-206
pubmed: 28734867
Biol Psychiatry. 2012 Apr 15;71(8):666-76
pubmed: 22153590
Neuropharmacology. 2020 Jun 15;170:108045
pubmed: 32217364
J Neurosci. 2015 Mar 4;35(9):3879-92
pubmed: 25740517
J Pharmacol Exp Ther. 2015 Nov;355(2):206-11
pubmed: 26350161
Trends Pharmacol Sci. 2013 Aug;34(8):437-44
pubmed: 23849813
Biol Psychiatry. 2014 Jun 1;75(11):873-83
pubmed: 24289884
Horm Behav. 2018 Jan;97:145-153
pubmed: 29037972
Eur J Pharmacol. 1995 Sep 5;283(1-3):151-9
pubmed: 7498304
Alcohol Clin Exp Res. 1996 Oct;20(7):1289-98
pubmed: 8904984
Science. 2004 Mar 5;303(5663):1512-4
pubmed: 15001778
Neuron. 2014 Jun 4;82(5):966-80
pubmed: 24908482
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8410-5
pubmed: 18541912
J Pharmacol Exp Ther. 1998 Jul;286(1):459-68
pubmed: 9655891
Front Behav Neurosci. 2013 Apr 19;7:32
pubmed: 23626528
J Comp Neurol. 1999 Oct 11;413(1):113-28
pubmed: 10464374
Cell Rep. 2019 Oct 1;29(1):13-21.e4
pubmed: 31577943
Neuropharmacology. 2017 Oct;125:418-428
pubmed: 28807676